QHL-1618
QHL-1618 is a drug conjugate activated by the tumor microenvironment. It effectively inhibits tumor growth in various models, such as HT-1080 and CT-26 xenografts.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62183R-APC-Cy7 100 µL
ZNF348/Kaiso Recombinant Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details 157077-01 10 µg
Toll Like Receptor Adaptor Molecule 2 (TICAM2) Recombinant, Human
Sign In for Pricing
View Details